These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


488 related items for PubMed ID: 27931259

  • 1. Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.
    Lipcsey M, Tenhunen J, Sjölin J, Frithiof R, Bendel S, Flaatten H, Kawati R, Kuitunen A, Tønnessen TI, Rubertsson S.
    Trials; 2016 Dec 08; 17(1):587. PubMed ID: 27931259
    [Abstract] [Full Text] [Related]

  • 2. Endotoxin Removal in Septic Shock with the Alteco LPS Adsorber Was Safe But Showed no Benefit Compared to Placebo in the Double-Blind Randomized Controlled Trial-the Asset Study.
    Lipcsey M, Tenhunen J, Pischke SE, Kuitunen A, Flaatten H, De Geer L, Sjölin J, Frithiof R, Chew MS, Bendel S, Kawati R, Larsson A, Mollnes TE, Tønnessen TI, Rubertsson S.
    Shock; 2020 Aug 08; 54(2):224-231. PubMed ID: 31880758
    [Abstract] [Full Text] [Related]

  • 3. Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis.
    Reinhart K, Meier-Hellmann A, Beale R, Forst H, Boehm D, Willatts S, Rothe KF, Adolph M, Hoffmann JE, Boehme M, Bredle DL, EASy-Study Group.
    Crit Care Med; 2004 Aug 08; 32(8):1662-8. PubMed ID: 15286541
    [Abstract] [Full Text] [Related]

  • 4. Endotoxin Elimination in Patients with Septic Shock: An Observation Study.
    Adamik B, Zielinski S, Smiechowicz J, Kübler A.
    Arch Immunol Ther Exp (Warsz); 2015 Dec 08; 63(6):475-83. PubMed ID: 26093653
    [Abstract] [Full Text] [Related]

  • 5. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
    Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C.
    JAMA; 2009 Jun 17; 301(23):2445-52. PubMed ID: 19531784
    [Abstract] [Full Text] [Related]

  • 6. [Selective hemoperfusion in gram-negative severe sepsis of patients after cardiac surgery: a prospective randomized study].
    Iarustovskiĭ MB, Abramian MV, Popok ZV, Nazarova EI, Stupchenko OS, Popov DA, Pliushch MG.
    Anesteziol Reanimatol; 2010 Jun 17; (5):60-5. PubMed ID: 21395144
    [Abstract] [Full Text] [Related]

  • 7. A new endotoxin adsorber in septic shock: observational case series.
    Ala-Kokko TI, Laurila J, Koskenkari J.
    Blood Purif; 2011 Jun 17; 32(4):303-9. PubMed ID: 21893976
    [Abstract] [Full Text] [Related]

  • 8. [Selective adsorption of endotoxin in the complex treatment of patients with severe sepsis].
    Khubutiia MSh, Abakumov MM, Aleksandrova IV, Reĭ SI, Il'inskiĭ ME, Khvatov VB, Borovkova NV, Pertsev AS, Zinkin VIu.
    Anesteziol Reanimatol; 2010 Jun 17; (5):65-9. PubMed ID: 21395145
    [Abstract] [Full Text] [Related]

  • 9. Use of an endotoxin adsorber in the treatment of severe abdominal sepsis.
    Kulabukhov VV.
    Acta Anaesthesiol Scand; 2008 Aug 17; 52(7):1024-5. PubMed ID: 18494849
    [Abstract] [Full Text] [Related]

  • 10. Endotoxin adsorbents in extracorporeal blood purification: do they fulfill expectations?
    Harm S, Falkenhagen D, Hartmann J.
    Int J Artif Organs; 2014 Mar 17; 37(3):222-32. PubMed ID: 24744167
    [Abstract] [Full Text] [Related]

  • 11. The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial.
    Klein DJ, Foster D, Schorr CA, Kazempour K, Walker PM, Dellinger RP.
    Trials; 2014 Jun 11; 15():218. PubMed ID: 24916483
    [Abstract] [Full Text] [Related]

  • 12. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).
    Zimmermann JB, Pinder N, Bruckner T, Lehmann M, Motsch J, Brenner T, Hoppe-Tichy T, Swoboda S, Weigand MA, Hofer S.
    Trials; 2017 Nov 10; 18(1):530. PubMed ID: 29126416
    [Abstract] [Full Text] [Related]

  • 13. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
    Uriu K, Osajima A, Hiroshige K, Watanabe H, Aibara K, Inada Y, Segawa K, Anai H, Takagi I, Ito A, Kamochi M, Kaizu K.
    Am J Kidney Dis; 2002 May 10; 39(5):937-47. PubMed ID: 11979337
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.
    Saito N, Sugiyama K, Ohnuma T, Kanemura T, Nasu M, Yoshidomi Y, Tsujimoto Y, Adachi H, Koami H, Tochiki A, Hori K, Wagatsuma Y, Matsumoto H.
    PLoS One; 2017 May 10; 12(3):e0173633. PubMed ID: 28358803
    [Abstract] [Full Text] [Related]

  • 15. Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected gram-negative sepsis.
    Balogun RA.
    Crit Care Med; 2005 Feb 10; 33(2):461-2. PubMed ID: 15699862
    [No Abstract] [Full Text] [Related]

  • 16. A new endotoxin adsorber: first clinical application.
    Ullrich H, Jakob W, Fröhlich D, Rothe G, Prasser C, Drobnik W, Taeger K, Meier-Hellmann A, Reinhart K, Zimmermann M, Schmitz G.
    Ther Apher; 2001 Oct 10; 5(5):326-34. PubMed ID: 11778916
    [Abstract] [Full Text] [Related]

  • 17. A trial to determine whether septic shock-reversal is quicker in pediatric patients randomized to an early goal-directed fluid-sparing strategy versus usual care (SQUEEZE): study protocol for a pilot randomized controlled trial.
    Parker MJ, Thabane L, Fox-Robichaud A, Liaw P, Choong K, Canadian Critical Care Trials Group and the Canadian Critical Care Translational Biology Group.
    Trials; 2016 Nov 22; 17(1):556. PubMed ID: 27876084
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of a novel endotoxin adsorber polyvinylidene fluoride fiber immobilized with (L)-serine ligand on septic pigs.
    Gao JP, Huang M, Li N, Wang PF, Chen HL, Xu QP.
    J Zhejiang Univ Sci B; 2011 Apr 22; 12(4):264-72. PubMed ID: 21462381
    [Abstract] [Full Text] [Related]

  • 19. Endotoxin removal: how far from the evidence? The EUPHAS 2 Project.
    Martin EL, Cruz DN, Monti G, Casella G, Vesconi S, Ranieri VM, Ronco C, Antonelli M.
    Contrib Nephrol; 2010 Apr 22; 167():119-125. PubMed ID: 20519906
    [Abstract] [Full Text] [Related]

  • 20. [The first experience in using selective sorbents in complex intensive care of patients with infectious and septic complications after cardiac surgery].
    Iarustovskiĭ MB, Abramian MV, Popok ZV, Nazarova EI, Stupchenko OS, Popov DA, Pliushch MG, Samsonova NN.
    Anesteziol Reanimatol; 2008 Apr 22; (6):49-55. PubMed ID: 19227295
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.